• https://www.facebook.com/fcadcom
  • http://www.twitter.com/fcadgroup
  • http://www.linkedin.com/company/fcad-group
  • https://vk.com/fcadgroup
  • https://t.me/fcadcom
  • http://fcadgroup.tumblr.com/
  • https://www.youtube.com/fcadgroup
  • https://www.caming.com/feed/
Please change screen to horizontal for better experience if you are checking Caming on your mobile phone. Email us by [email protected] or visit our sales website www.watson-Int.com
Caming Pharmaceutical Ltd - Focusing on development of pharmaceutical-related chemicals
  • About Caming
  • Key Products
    • Polyethylene Glycol
    • COVID-19 Related
    • Impurities
  • Pharmaceutical Chemicals
    • APIs
    • Intermediates
    • Steroid Hormones
    • Impurities
    • Excipients
    • Others
  • Animal Health
  • Diagnostic Reagents
  • R&D
  • Contact Us
  • Visit FCAD

Tag Archives: «Temsirolimus»

0
Temsirolimus CAS 162635-04-3

Temsirolimus CAS 162635-04-3

In APIs, Pharmaceutical Chemicals, Products

162635-04-3,Temsirolimus,

0
Temsirolimus CAS 162635-04-3

Temsirolimus CAS 162635-04-3

In APIs, Pharmaceutical Chemicals, Products

162635-04-3,Temsirolimus,Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate

To Support Covid-19 Diagnostics

COVID-19 IgG/IgM Rapid Test Device Available

Remdesivir Key Intermediates to fight again COVID-19

New Products

  • 1-Bromo-3,5-dichlorobenzene CAS 19752-55-7
  • Oxytetracycline EP Impurity A CAS 14206-58-7
  • Ritonavir EP Impurity R CAS 1414933-80-4
  • Rifaximin EP Impurity G CAS 80621-76-7
  • Pregabalin Amide Lactose Adduct CAS 501665-88-9
Copyright © 2023 Caming Pharmaceutical Ltd - Committed to APIs, Intermediates, Impurities, Veterinary Products & Diagnostic Reagents | A FCAD Company